Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Autophagy Rep. 2022 Dec 25;2(1):1–16. doi: 10.1080/27694127.2022.2155904

Figure 2:

Figure 2:

Top I inhibition triggers autophagy via m-TOR suppression. Topoisomerase I inhibition by irinotecan or topotecan generates reactive oxygen species (ROS), which drives the activation of JNK/AMP and p38/MAPK. JNK phosphorylation activates SESN2, followed by AMPK. p38 activation via ROS upregulates MAPK. These two pathways converge on m-TOR, where m-TOR inhibition triggers autophagic flux.